Concepedia

Vladimir Perkov

VP

Statistics

Publications

4

Citations

163

H-Index

4

Active since

2022

Affiliations

Sanofi (France)(Current)

Vladimir Perkov is an author at Sanofi (France) specializing in lipid nanoparticles, vaccinology, and vaccine delivery.

ORCID

Publications per year

2022–2024

4

Publications

4

An imidazole modified lipid confers enhanced mRNA-LNP stability and strong immunization properties in mice and non-human primates

Manon Ripoll, Marie‐Clotilde Bernard, Céline Vaure et al. · Biomaterials · 2022 · 75 citations · Full text

, , +17

The impact of nucleoside base modification in mRNA vaccine is influenced by the chemistry of its lipid nanoparticle delivery system

Marie‐Clotilde Bernard, Emilie Bazin, Nadine Petiot et al. · Molecular Therapy — Nucleic Acids · 2023 · 55 citations · Full text

, , +17

Distinct dynamics of mRNA LNPs in mice and nonhuman primates revealed by in vivo imaging

Katia Lemdani, Romain Marlin, Céline Mayet et al. · npj Vaccines · 2024 · 21 citations · Full text

, , +17

Nonclinical safety assessment of an mRNA Covid‐19 vaccine candidate following repeated administrations and biodistribution

Karine Broudic, Sébastien Laurent, Vladimir Perkov et al. · Journal of Applied Toxicology · 2023 · 12 citations · Full text

, , +17

1–4 of 4